✦ LIBER ✦

Orlistat treatment is safe in overweight and obese liver transplant recipients: a prospective, open label trial

✍ Scribed by David Cassiman; Mieke Roelants; Gerda Vandenplas; Schalk W. Van der Merwe; Ann Mertens; Louis Libbrecht; Chris Verslype; Johan Fevery; Raymond Aerts; Jacques Pirenne; Erik Muls; Frederik Nevens

Book ID: 110916750
Publisher: Springer
Year: 2006
Tongue: English
Weight: 111 KB
Volume: 19
Category: Article
ISSN: 0934-0874
DOI: 10.1111/j.1432-2277.2006.00379.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

152 A prospective open, single arm, pilo

152 A prospective open, single arm, pilot trial to assess the safety and efficacity of orlistat in obese liver transplant patients

✍ F. Nevens; G. Vandenplas; E. Muls; M. Roelands; C. Verslype; R. Aerts; J. Fevery 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Early ribavirin treatment and avoidance

Early ribavirin treatment and avoidance of corticosteroids in hepatitis C virus (HCV)-positive liver transplant recipients: interim report of a prospective randomized trial

✍ L.S Belli; A.B Alberti; G.F Rondinara; L de Carlis; A Corti; E Mazza; A Airoldi; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 66 KB